Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease
Clinical trial NCT05197712 · UNKNOWN
Trial details
- NCT number
- NCT05197712
- Sponsor
- Baiya Phytopharm Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2023-05-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.